Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study

by Rosario Palacios MD, PhD, M. Mayorga MD, C. M. González-Domenech PhD, C. Hidalgo-Tenorio MD, PhD, C. Gálvez MD, PhD, L. Muñoz-Medina MD, J. de la Torre MD, PhD, A. Lozano MD, M. Castaño MD, M. Omar MD, PhD, Jesús Santos MD, PhD
Published 2018-03-01